These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 14699593

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The effect of plasmapheresis and other immunomodulating therapies on the course of severe Guillain-Barré syndrome].
    Hidasi E, Soltész P.
    Orv Hetil; 2001 Feb 18; 142(7):335-9. PubMed ID: 11243015
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Guillain-Barré syndrome in childhood].
    Kollár K, Liptai Z, Rosdy B, Móser J.
    Ideggyogy Sz; 2009 Nov 30; 62(11-12):399-404. PubMed ID: 20025130
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A, Huerta Villanueva M, Olivé Plana M, Montero Homs J, Serra Catafau J, Martínez-Matos JA.
    Neurologia; 1998 Apr 30; 13(4):166-9. PubMed ID: 9608755
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Guillain-Barré syndrome: rehabilitation outcome and recent developments.
    Melillo EM, Sethi JM, Mohsenin V.
    Yale J Biol Med; 1998 Apr 30; 71(5):383-9. PubMed ID: 10527365
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
    Kuitwaard K, de Gelder J, Tio-Gillen AP, Hop WC, van Gelder T, van Toorenenbergen AW, van Doorn PA, Jacobs BC.
    Ann Neurol; 2009 Nov 30; 66(5):597-603. PubMed ID: 19938102
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic factors and complication rates for double-filtration plasmapheresis in patients with Guillain-Barré syndrome.
    Lin JH, Tu KH, Chang CH, Chen YC, Tian YC, Yu CC, Hung CC, Fang JT, Yang CW, Chang MY.
    Transfus Apher Sci; 2015 Feb 30; 52(1):78-83. PubMed ID: 25544386
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.